Spotlight survey on the validation of biomarkers
AI-driven precision medicine in oncology.
For the next 3 months we will focus on the validation of biomarkers. During this Spotlight, we will be revisiting some of the key issues raised in a previous Spotlight: Biomarkers (and biosensors), as well as investigating advancements in the field and the development of techniques.
COMPLETE SURVEY NOW
To kick-start this special focus, we wanted to hear your thoughts on the topic – click here to complete our short survey on the validation of biomarkers and be the first to receive our informative infographic collated from the survey results.
